Rationale for osteoporosis screening in men

Area of Science:

• Gerontology
• Endocrinology
• Public Health

Background:

• The US Preventive Services Task Force (USPSTF) has not established evidence-based guidelines for osteoporosis screening in men.
• Osteoporosis affects men and poses a significant fracture risk, yet screening remains under-addressed.

Purpose of the Study:

• To review the existing literature on osteoporosis screening and treatment specifically in men.
• To establish a consensus among Department of Veterans Affairs (VA) clinicians regarding male osteoporosis management.

Main Methods:

• A literature review was conducted by a panel of 20 experienced VA clinicians specializing in male osteoporosis.
• Consensus was achieved through virtual meetings and extensive email communication.

Main Results:

• Targeted screening effectively identifies men at elevated risk for osteoporotic fractures.
• Pharmacological interventions for osteoporosis demonstrate comparable efficacy in reducing fracture risk for both men and women.
• Recent studies indicate that current osteoporosis medications significantly lower hip fracture risk in men, mirroring effects seen in women.

Conclusions:

• The panel reached a consensus that implementing targeted osteoporosis screening in men would enhance medication utilization.
• Increased use of osteoporosis medications is expected to lead to a reduction in fracture incidence among the male population.